Effect of photobiomodulation after non‐surgical mechanical debridement on cortisol levels in the peri‐implant sulcular fluid among patients with peri‐implant mucositis

Alhumaidan, Abdulkareem A.; Alali, Yasser; Ahmed, Suhaib; Vohra, Fahim; Abduljabbar, Tariq

doi:10.1111/phpp.12774

Cited by 4 publications

(1 citation statement)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A very recent trial on the efficacy of photobiomodulation after non-surgical mechanical debridement in patients with peri-implant mucositis evaluated cortisol levels in periimplant sulcular fluid, modified plaque index, modified gingival index, and probing depth. Interestingly, over a short-term of follow-up, the use of photobiomodulation did not show additional benefits in terms of reducing soft-tissue inflammatory parameters and cortisol levels [8].…”

Section: Introductionmentioning

confidence: 89%

Treatment of Peri-Implant Mucositis with Standard of Care and Bioptron Hyperlight Therapy: A Randomized Clinical Trial

Nardi

Mazur

Papa

et al. 2022

IJERPH

View full text Add to dashboard Cite

The aim of this study was to evaluate in a cohort of patients with peri-implant mucositis: (a) the efficacy of professional mechanical debridement therapy assisted using Bioptron Hyperlight Therapy on the reduction in periodontal indexes and (b) the reduction in total oxidative salivary stress. Forty subjects with a diagnosis of peri-implant mucositis were enrolled and randomly assigned to the Study Group (mechanical debridement therapy assisted using Bioptron Hyperlight Therapy) or Control Group (mechanical debridement therapy alone). The study duration was 6 months. Data on plaque index (PI), bleeding on probing (BoP), probing pocket depth (PPD), and pain relief on Visual Analogue Scale (VAS) were recorded at T0, T1 (14 days), T2 (1 month), and T3 (6 months). Group differences were assessed using Student’s t-test and Pearson’s Chi-squared test of homogeneity. PI and PPD decreased in the Study Group at the [T0; T1] time interval and during the overall time of observation significantly more than in the Control Group; BoP and pain on VAS decreased significantly faster in the Study Group than in the Control Group. Differences in Salivary Antioxidant Test (SAT) changes were not significant at any time interval. Patients’ gender and smoking habit were not correlated with the clinical outcomes. Clinical parameters related to peri-implant mucositis significantly improved in the Study Group, which demonstrated the clinical efficacy of the Bioptron Hyperlight Therapy as an adjunct to standard of care for the treatment of peri-implant mucositis. The RCT was registered at the US National Institutes of Health #NCT05307445.

show abstract

Section: Introductionmentioning

confidence: 89%